Close

Send to a Friend Font Size: Increase Decrease

Broadfin Capital

Broadfin Capital's Portfolio

Ticker	# of Shares	Price	Value
	5,574,366	$1,141.93	$6,365,535,767
	2,707,851	$1,141.93	$3,092,176,293
	2,000,000	$1,141.93	$2,283,860,000
	1,839,372	$1,141.93	$2,100,434,068
	1,236,368	$1,141.93	$1,411,845,711
	1,029,012	$1,141.93	$1,175,059,674
	1,003,099	$1,141.93	$1,145,468,842
	721,073	$1,141.93	$823,414,891
	617,953	$1,141.93	$705,659,070
	600,000	$1,141.93	$685,158,000
View Additional Portfolio Information »

Broadfin Capital

Login to help us fill in information about this entity.

Form SC 13G/A RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC Feb 10, 2017 04:09PM

RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results Feb 25, 2016 08:00AM

Form SC 13G/A RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC Feb 12, 2016 06:04AM

RedHill Biopharma Reports Results for the Third Quarter of 2015 Nov 9, 2015 07:00AM

RedHill Biopharma Reports Results for the Second Quarter of 2015 Jul 29, 2015 06:05AM

Jul 22, 2015 10:10AM RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
Apr 30, 2015 07:00AM RedHill Biopharma Reports Results for the First Quarter of 2015
Feb 26, 2015 04:00PM Form SC 13G RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC